▟ Vinebot intrinsic value, daily

← back

BAX Baxter International

healthcare · valued with glm-5.2 medium conviction · deep-dived 2026-08-18

STRONG SELL
Intrinsic value$0.00
Price (at call)$25.91
Margin of safety -100.0%
vs market (rating basis) -79.4%

Model unavailable; showing baseline valuation.

⚠ LLM error: empty response; using baseline

The story

Value drivers

Revenue growth (Y1)3.8%
Terminal growth3.5%
Forecast horizon10y
Target operating margin-1.7%
Years to target margin5
Sales-to-capital0.74
Beta0.59
Failure probability0.0%
Cost of capital (WACC)6.7%
Terminal WACC7.4%

Valuation bridge

PV of explicit FCFF-6.01B
PV of terminal value-1.58B
Equity value0
÷ shares → per share$0.00

News

bullish +0.60 · 8 articles

  • 3 Stocks Under $50 with Questionable Fundamentals
  • WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?
  • Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins
  • Does Cardinal Health’s New CAO and Recalls Reveal Shifts in Its Risk Profile and Earnings Quality (CAH)?
  • Baxter (BAX) Stock Gets Fair Value Boost After Q2 Beat And Higher Targets
  • Baxter International (BAX) Is Up 16.8% After Raising 2026 Sales Outlook And Earnings Guidance
  • Baxter International Q2 Earnings Call Highlights
  • Why Baxter International Stock Skyrocketed by 19% This Week

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 11.90B 3.8% -1.7% -156.61M 591.25M -747.86M -700.93M
2 12.35B 3.8% -1.7% -162.49M 608.46M -770.95M -677.22M
3 12.81B 3.7% -1.7% -168.54M 625.92M -794.46M -654.08M
4 13.28B 3.7% -1.7% -174.77M 643.64M -818.41M -631.50M
5 13.77B 3.7% -1.7% -181.16M 661.61M -842.77M -609.49M
6 14.27B 3.6% -1.7% -187.74M 679.81M -867.55M -588.04M
7 14.78B 3.6% -1.7% -194.49M 698.24M -892.73M -567.13M
8 15.31B 3.6% -1.7% -201.42M 716.90M -918.32M -546.78M
9 15.85B 3.5% -1.7% -208.53M 735.77M -944.30M -526.96M
10 16.41B 3.5% -1.7% -215.83M 754.83M -970.66M -507.68M

⚠ intrinsic value floored at 0 — the drivers imply the equity claim is worth less than the debt ahead of it · Extreme gap to market price — large, heavily-covered stocks are rarely mispriced this much; the gap likely embeds disruption, decline, or balance-sheet risk the model underweights. Treat as a flag to investigate, not a verdict.

History

DatePriceIntrinsicMoSRating
2026-08-18$25.91 $0.00 -100.0% STRONG SELL
2026-06-26$21.55 $11.99 -44.4% HOLD
2026-06-23$20.10 $4.06 -79.8% STRONG SELL